Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of responseVOLLENHOVEN, Ronald F.van; PETRI, Michelle A; CERVERA, Ricard et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 8, pp 1343-1349, issn 0003-4967, 7 p.Article

Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging StudySTOHL, William; MERRILL, Joan T; MCKAY, James D et al.Journal of rheumatology. 2013, Vol 40, Num 5, pp 579-589, issn 0315-162X, 11 p.Article

Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 TrialWINN CHATHAM, W; WALLACE, Daniel J; ZHONG, Z. John et al.Journal of rheumatology. 2012, Vol 39, Num 8, pp 1632-1640, issn 0315-162X, 9 p.Article

Long-Term Safety Profile of Belimumab Plus Standard Therapy in Patients With Systemic Lupus ErythematosusMERRILL, Joan T; GINZLER, Ellen M; PINEDA, Lilia et al.Arthritis and rheumatism. 2012, Vol 64, Num 10, pp 3364-3373, issn 0004-3591, 10 p.Article

Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus ErythematosusGINZLER, Ellen M; WALLACE, Daniel J; FREIMUTH, William W et al.Journal of rheumatology. 2014, Vol 41, Num 2, pp 300-309, issn 0315-162X, 10 p.Article

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialNAVARRA, Sandra V; GUZMAN, Renato M; TANASESCU, Coman et al.Lancet (British edition). 2011, Vol 377, Num 9767, pp 721-731, issn 0140-6736, 11 p.Article

A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus ErythematosusFURIE, Richard; PETRI, Michelle; STOHL, William et al.Arthritis and rheumatism. 2011, Vol 63, Num 12, pp 3918-3930, issn 0004-3591, 13 p.Article

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus ErythematosusWALLACE, Daniel J; STOHL, William; FERNANDEZ, Vivian et al.Arthritis care and research. 2009, Vol 61, Num 9, pp 1168-1178, issn 0893-7524, 11 p.Article

Novel Evidence-Based Systemic Lupus Erythematosus Responder IndexFURIE, Richard A; PETRI, Michelle A; ZHONG, Z. John et al.Arthritis care and research. 2009, Vol 61, Num 9, pp 1143-1151, issn 0893-7524, 9 p.Article